ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIE...

por Cerna, Karin, Duricova, Dana, Lukas, Martin, Machkova, Nadezda, Hruba, Veronika, Lukas, Milan
Publicado 2022

Impaired Deoxyribonuclease I Activity in Patients with Inflammatory Bowel Diseases

por Malíčková, Karin, Ďuricová, Dana, Bortlík, Martin, Hrušková, Zdenka, Svobodová, Barbora, Machková, Naděžda, Komárek, Viktor, Fučíková, Terezie, Janatková, Ivana, Zima, Tomáš, Lukáš, Milan
Publicado 2011

Subcutaneous Infliximab in Refractory Crohn’s Disease Patients: A Possible Biobetter?

por Cerna, Karin, Duricova, Dana, Lukas, Martin, Kolar, Martin, Machkova, Nadezda, Hruba, Veronika, Mitrova, Katarina, Kubickova, Kristyna, Kostrejova, Marta, Jirsa, Jakub, Kastylova, Kristyna, Peterka, Stepan, Vojtechova, Gabriela, Lukas, Milan
Publicado 2023